Duckbill Drugs Pvt Ltd - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U24232WB1994PTC063258 Incorporated 19 May 1994 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹7.2 Cr
▲ 334% YoY
Net profit · FY 2025
₹80.56 Lakh
Net margin 11.2%
EBITDA · FY 2025
₹1.16 Cr
EBITDA margin 16.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹87 Lakh
Issued & subscribed
Satisfied charges
₹8.15 Cr
No open charges
Company age
32 yrs
Est. 1994
Employees · EPFO
56
Provident fund records

About Duckbill Drugs Pvt Ltd

Data last updated:

Duckbill Drugs Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 May 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1994PTC063258. Its GSTIN is 19AABCD3045J1ZP (West Bengal).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹87 Lakh. It is led by directors including Asoke Kumar Paul and Reeta Paul.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.2 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹80.56 Lakh (net margin 11.2%) and EBITDA of ₹1.16 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over five years.

The company has about 56 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Duckbill Drugs. As per MCA filings, the company has satisfied charges of ₹8.15 Cr on record. Court records list 23 cases involving the company, including 10 filed by the company and 13 filed against it; 8 cases are pending.

Duckbill Drugs Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0006902). The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U24232WB1994PTC063258
Registration Number 063258
Incorporation Date 19 May 1994
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Non-Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0006902

Recognitions & Rankings of Duckbill Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2020-21)
Udyam number
UDYAM-WB-10-0006902

Contact details

Duckbill Drugs Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.

  • Email
  • Registered Address
    7 Kali Prasanna Chatterjee Lane, Ground Floor, Kolkata, West Bengal, India – 700034
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Duckbill Drugs Pvt Ltd, buy the company report.

Comprehensive company report
Duckbill Drugs Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Duckbill Drugs operates one associated brand: Duckbill Drugs. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures pharmaceutical products and distributes across Eastern India for healthcare needs.duckbilldrugs.com

Business activity

The main business activity of Duckbill Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Duckbill Drugs Pvt Ltd, buy the company report.

Financials of Duckbill Drugs Pvt Ltd

FY 2025 filings available

Duckbill Drugs Pvt Ltd reported revenue of ₹7.2 Cr (up 334% YoY) for FY 2025.

Revenue · FY 2025
₹7.2 Cr ▲ 334%
Net profit · FY 2025
₹80.56 Lakh margin 11.2%
EBITDA · FY 2025
₹1.16 Cr margin 16.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 334%
5 years · compounded
▲ 3%

Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 334% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.16 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹80.56 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin16.1%
Net Profit Margin11.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Duckbill Drugs Pvt Ltd, buy the company report.

Board of directors of Duckbill Drugs Pvt Ltd

Duckbill Drugs has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Asoke Kumar PaulDirector30 Mar 20233 Years 7 MonthsCurrent
Reeta PaulDirector30 Mar 20233 Years 7 MonthsCurrent
Sangita PaulDirector30 Mar 20233 Years 7 MonthsCurrent
Tapan PaulDirector30 Mar 20233 Years 7 MonthsCurrent

Peer comparison

Duckbill Drugs Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
SKM Pharma Private Limited,₹7.26 Cr (FY 2025)-32.0%Bangalore, Karnataka, India
Skybiotech Life Sciences Private Limited₹7.25 Cr (FY 2025)-36.0%Aurangabad, Maharashtra, India
Duckbill Drugs Pvt Ltdthis company₹7.2 Cr (FY 2025)₹80.56 Lakh11.2%334.0%56Kolkata, West Bengal, India
Serin Formulations Private Limited₹7.2 Cr (FY 2025)-2.0%Hyderabad, Telangana, India

To see the full peer comparison of Duckbill Drugs Pvt Ltd, buy the company report.

Auditor

Duckbill Drugs Pvt Ltd is audited by M G S K & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
M G S K & ASSOCIATESFY 2020328275E

Shareholding

The shareholding of Duckbill Drugs Pvt Ltd is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Duckbill Drugs Pvt Ltd, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹8.15 Cr
Breakdown by lending institutions
Punjab National Bank₹2.99 Cr
State Bank of India₹2.96 Cr
The Federal Bank Limited₹2.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Oct 201110320594State Bank of India₹1.88 CrSatisfied
05 Mar 200910151239Punjab National Bank₹2.99 CrSatisfied
06 Mar 200680052054The Federal Bank Limited₹2.2 CrSatisfied
19 Jul 200380009272State Bank of India₹1.08 CrSatisfied

To see the full charge records of Duckbill Drugs Pvt Ltd, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Duckbill Drugs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Duckbill Drugs Pvt Ltd has a workforce of 56 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
56
Active EPFO establishments
1
Employee growth
-1.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2756
FY 2025-26
FY 2024-25
FY 2023-24
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17
FY 2015-16

To see the full employee and EPFO history of Duckbill Drugs Pvt Ltd, buy the company report.

GST

Duckbill Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AABCD3045J1ZPWest BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Duckbill Drugs Pvt Ltd, buy the company report.

Recent activity

Duckbill Drugs Pvt Ltd has 12 board changes on record since 2013: 4 appointments and 8 cessations. The latest: Asoke Kumar Paul ceased to be Additional Director on 29 Sep 2023.

AGM
Duckbill Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Duckbill Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Charges
A charge registered on 18 Oct 2011 via Charge ID 10320594 with State Bank Of India was fully satisfied on 06 May 2024.
Ceased
Asoke Kumar Paul ceased to be Additional Director.
Ceased
Reeta Paul ceased to be Additional Director.
Ceased
Sangita Paul ceased to be Additional Director.
Ceased
Tapan Paul ceased to be Additional Director.
Appointed
Asoke Kumar Paul was appointed as Director.
Appointed
Reeta Paul was appointed as Director.
Appointed
Sangita Paul was appointed as Director.
Appointed
Tapan Paul was appointed as Director.
Ceased
Arjun Mukherjee ceased to be Director.

12 earlier events are in the company report.

Frequently asked questions

Duckbill Drugs is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 May 1994 (32+ years old) and is registered under CIN U24232WB1994PTC063258.

Duckbill Drugs has 4 current directors:

The latest financial statements of Duckbill Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Duckbill Drugs is 19AABCD3045J1ZP, registered in West Bengal.

The CIN (Corporate Identification Number) of Duckbill Drugs is U24232WB1994PTC063258. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Duckbill Drugs has 23 court cases on record: 10 filed by the company and 13 filed against it. 8 are pending. Most are in the high courts.

Duckbill Drugs was incorporated on 19 May 1994, making it 32+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Duckbill Drugs by revenue are SKM Pharma Private Limited,, Skybiotech Life Sciences Private Limited, Serin Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Asoke Kumar Paul ceased to be Additional Director on 29 Sep 2023. Reeta Paul ceased to be Additional Director on 29 Sep 2023. Sangita Paul ceased to be Additional Director on 29 Sep 2023. Duckbill Drugs has 12 board changes on record in total.

Yes, Duckbill Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0006902).

The registered office of Duckbill Drugs is at 7 Kali Prasanna Chatterjee Lane, Ground Floor, Kolkata, West Bengal, India – 700034.